NPSA Appendix 1 Injectable Medicines Risk Assessment Tool
syringe drivers are available for use, and users have knowledge of when this equipment should be used Use of unlabelled syringes and / or infusion bags (unless allowed by practice guideline) Re-inforce and audit policy to ensure all parenteral syringes and infusions are labelled for use Use of an injectable medicine ampoule, vial or infusion
Tags:
Drivers, Syringes, Syringe driver
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Documents from same domain
Clinical protocol for the use of syringe drivers in ...
www.palliativedrugs.comsyringe drivers in palliative care patients (adults) ... • Once the alarm has fi nished, releasing the button starts the syringe driver • Do not use the pump if the motor does not stop or the alarm does not sound • Check that the indicator lamp is fl ashing (the lamp will begin to …
Patients, Drivers, Pumps, Care, Adults, Palliative, Syringes, Syringe drivers in palliative care patients
Isle of Wight Syringe Driver Compatibility Guidelines
www.palliativedrugs.comThis is intended to guide primary and secondary care clinicians throughout the Isle of Wight in deciding which medicines can be combined for use with subcutaneous syringe drivers. Roles and responsibilities Adherence to St Marys Medicines Policy, and to GMC, NMC and GPhC professional standards, are assumed: users of
Anticipatory drugs and syringe driver chart V2
www.palliativedrugs.comSyringe driver combinations containing octreotide, methadone, ketorolac, ketamine or furosemide Pr escribe appr o v ed name o f drug en t er ed in C A P I T A L S Diluen ts R esour c es f or in f orma tion F or pa tien ts with r enal f ailur e Please if uncertain about drug compatibilities seek advice Specialist palliative care/ hospice ...
Drug, Drivers, Care, Palliative, Syringes, Palliative care, Compatibilities, Syringe driver, Drug compatibilities
Guidelines for Ketamine Use - © palliativedrugs.com
www.palliativedrugs.comSt Joseph's Mercy Hospice Auckland NZ Guidelines for Ketamine Use Ketamine is a dissociative anaesthetic agent which has analgesic properties in sub-
SUMMARY OF PRODUCT CHARACTERISTICS - © …
www.palliativedrugs.comSUMMARY OF PRODUCT CHARACTERISTICS 1. Name of the medicinal product OxyNorm 10 mg/ml, solution for injection or infusion 2. Qualitative and Quantitative Composition Oxycodone hydrochloride 10 mg/ml
Product, Summary, Characteristics, Summary of product characteristics
090714 opioid conversions - © palliativedrugs.com
www.palliativedrugs.comChoice of opioid This is obviously dependent on the individual patient, but as a general rule, use: • Morphine as first line opioid via oral and subcutaneous routes
These Guidelines were originally developed for Mercy ...
www.palliativedrugs.comGUIDELINES FOR WOUND MANAGEMENT IN PALLIATIVE CARE Wayne Naylor - BSc(Hons), PG Cert (Palliative Care), Dip Nursing, Oncology cert. (ENB 237), RCompN Wayne Naylor is a New Zealand registered nurse who began his career in forensic
Use of dexamethasone formulations in palliative care: a ...
www.palliativedrugs.com8–16mg 6.6–13.2mg (2–4mL) 7.6–15.2mg (2–4mL) Spinal cord compression 16mg 13.2mg (4mL) 15.2mg (4mL) a. generally given once daily in the morning (see text) b. prednisolone 15−40mg each morning is an alternative c. also see PCF Quick Prescribing Guide: Management of nausea and vomiting. Table 2 ...
Subcutaneous hydration in palliative care v2.4 Final
www.palliativedrugs.comto palliative care patients in all care environments. 1.2 It has been produced to ensure consistent practice, use and equitable access to subcutaneous fluids across the West Midlands region. 2 Guideline Background 2.1 Subcutaneous hydration (previously known as hypodermoclysis) is a technique used for
Care, Palliative, Hydration, Subcutaneous, Palliative care, All care, Subcutaneous hydration in palliative care
Modified-release preparations
www.palliativedrugs.comWhat is modified-release? The term modified-release defines preparations that have been designed in such a way that the rate or place at which the active ingredients are released has been modified.2 This is an all encompassing term that the BNF now uses to cover prepara-tions such as sustained-release, controlled-release and delayed-release.
Related documents
Guidelines for Syringe Driver Management in Palliative Care
www.health.qld.gov.auSyringe Driver Guidelines Background Syringe drivers are defined as power driven devices that drive the plunger of a syringe at an accurately controlled rate to deliver medications10. Their use as a method of drug delivery to control symptoms in palliative care is a common and accepted practice. They provide symptom control via
Isle of Wight Syringe Driver Compatibility Guidelines
www.palliativedrugs.commedicines can be combined for use with subcutaneous syringe drivers. Roles and responsibilities Adherence to St Marys Medicines Policy, and to GMC, NMC and GPhC professional standards, are assumed: users of this booklet need to use their clinical judgement, and if in doubt, seek advice from other sources. Layout The 3rd column indicates the diluent
Guidelines for Subcutaneous Infusion in Palliative Care
www.health.qld.gov.aufrom previous reviews were included: syringe drivers, subcutaneous infusions, end-of-life care, palliative care, subcutaneous infusion devices, McKinley T34, Niki T34 and CADD. This review extended the previous search terms to include patient and carer experience of use of subcutaneous devices at end of life and additional search terms: patient
Clinical Guideline Pain Management
mm.wirral.nhs.ukAnalgesic subcutaneous syringe drivers Co-prescribing with opioids Appendix 1: Dose conversion chart for strong opioids WHO Analgesic Ladder The WHO analgesic ladder is a validated system for treating pain. Step 3. Moderate to Severe Pain Strong Opioid: Morphine Sulphate, Diamorphine, Fentanyl + non opioid Step 2.
The Palliative Care Handbook - Hospice
www.hospice.org.nz• There is also information about the use of syringe drivers. While drug information in this book relates primarily to availability in Australia and New Zealand, the medications will generally be available in the UK, US and internationally. Where needed, further information is available from your nation’s regulatory agency
Safe management of healthcare waste
www.wsh.nhs.uksyringe drivers / PCAs / epidurals, used patches. See NSCDSOP010 CD denaturing kit Unknown medicines Loose tablets and capsules, doses of liquid medicines Purple lidded sharps container. Title: Waste Management Staff Leaflet Author: t.lawrence Created Date: